Industry News
Pharmaceutical Industry News
Biogen’s Aduhelm, already battling US skepticism, faces likely European rejection
Biogen’s Aduhelm, already battling US skepticism, faces likely European rejection aliu Wed, 11/17/2021 - 09:28
Pfizer’s D’Amelio retires, spurring ‘external’ CFO search and prompting company to name new supply chief
Pfizer's D'Amelio retires, spurring 'external' CFO search and prompting company to name new supply chief fkansteiner Wed, 11/17/2021 - 09:08
GlaxoSmithKline and Vir finally score $1B supply deal for COVID antibody—6 months after FDA nod
GlaxoSmithKline and Vir finally score $1B supply deal for COVID antibody—6 months after FDA nod kdunleavy Wed, 11/17/2021 - 09:05
U.S. to Buy Enough of Pfizer’s Covid Antiviral Pills for 10 Million People
The antiviral drugs have helped inspire hope among senior administration officials that the United States will be able to curb the devastating toll from the Delta variant.
F.D.A. Plans to Authorize Pfizer Boosters for All Adults This Week
Regulators are set to clear extra doses of Pfizer-BioNTech’s vaccine as soon as Thursday, after states began expanding eligibility on their own.
Pfizer Asks F.D.A. to Authorize Covid Pill For High-Risk Unvaccinated People
. The request is for use in unvaccinated, high risk patients. But the regulator could authorize it for broader use.
Pfizer Will Allow Its Covid Pill to Be Made and Sold Cheaply in Poor Countries
The company announced a deal that could help significantly expand access to the Covid-19 treatment, but the agreement excludes a number of countries hit hard by the pandemic.
Pfizer, US in talks for ‘multibillion-dollar’ supply deal for COVID-19 pill: WaPo
Pfizer, US in talks for 'multibillion-dollar' supply deal for COVID-19 pill: WaPo fkansteiner Tue, 11/16/2021 - 15:44
Moderna, amid mounting pressure to address vaccine inequality, says it’s working on new COVAX deal
Moderna, amid mounting pressure to address vaccine inequality, says it's working on new COVAX deal kdunleavy Tue, 11/16/2021 - 11:34
Viatris launched two versions of its interchangeable insulin biosimilar. Why?
Viatris launched two versions of its interchangeable insulin biosimilar. Why? fkansteiner Tue, 11/16/2021 - 10:55
Viatris launched 2 versions of its interchangeable insulin biosimilar. Why?
Viatris launched 2 versions of its interchangeable insulin biosimilar. Why? fkansteiner Tue, 11/16/2021 - 10:55
MyLife, with COVID-19 in its sights, raises cash to advance vaccine patch delivery tech
MyLife, with COVID-19 in its sights, raises cash to advance vaccine patch delivery tech ntaylor Tue, 11/16/2021 - 09:52
Novartis sees future beyond eye drops, bagging option to buy developer of drug delivery tech
Novartis sees future beyond eye drops, bagging option to buy developer of drug delivery tech ntaylor Tue, 11/16/2021 - 09:22
Pharma-backed ‘Destination Healthy Skin’ RV nears end of 2021 road tour
Pharma-backed ‘Destination Healthy Skin’ RV nears end of 2021 road tour nmissakian Tue, 11/16/2021 - 09:16
Cell and gene therapy player CBM plots expansion, 2,000 new hires with funding from South Korean partner
Cell and gene therapy player CBM plots expansion, 2,000 new hires with funding from South Korean partner jkeenan Tue, 11/16/2021 - 08:58
AbbVie’s ‘unsupported’ price hikes on Humira drove $1.4B in extra U.S. drug spending, ICER says
AbbVie's 'unsupported' price hikes on Humira drove $1.4B in extra U.S. drug spending, ICER says fkansteiner Tue, 11/16/2021 - 08:55
Buffett’s Berkshire exited Merck investment just before COVID pill boost, further trimmed AbbVie and BMS holdings
Buffett's Berkshire exited Merck investment just before COVID pill boost, further trimmed AbbVie and BMS holdings aliu Tue, 11/16/2021 - 08:14
List Bio to build new $125M microbiome plant in Indiana, hire 210
List Bio to build new $125M microbiome plant in Indiana, hire 210 jkeenan Tue, 11/16/2021 - 08:00
Pfizer, like Merck, inks deal to license COVID-19 pill and boost global supply
Pfizer, like Merck, inks deal to license COVID-19 pill and boost global supply kdunleavy Tue, 11/16/2021 - 06:50
AbbVie re-ups University of Chicago cancer pact, extending alliance out to 2025 after drug delivery progress
AbbVie re-ups University of Chicago cancer pact, extending alliance out to 2025 after drug delivery progress ntaylor Tue, 11/16/2021 - 06:47